Latest News and Press Releases
Want to stay updated on the latest news?
-
LEXINGTON, Ky., Dec. 11, 2015 (GLOBE NEWSWIRE) -- Transposagen, Inc. today announced that it has entered into a non-exclusive license agreement with the Broad Institute to access intellectual...
-
LEXINGTON, Ky., June 16, 2015 (GLOBE NEWSWIRE) -- Transposagen Biopharmaceuticals, Inc. (“Transposagen”), a privately-held biotechnology company, has accepted the highly prestigious 2015 Tibbetts...
-
LEXINGTON, Ky., June 16, 2015 (GLOBE NEWSWIRE) -- Aragen Bioscience, Inc. (“Aragen Bioscience”), in partnership with Transposagen Biopharmaceuticals, Inc. (“Transposagen), has developed a FUT8...
-
Lexington, KY, Apr. 20, 2015 (GLOBE NEWSWIRE) -- Transposagen, a world leader in genome engineering technologies and services, announced the registration of its trademark OncoRat™ by the USPTO, for...
-
Lexington, KY, Apr. 20, 2015 (GLOBE NEWSWIRE) --...
-
Lexington, KY, Apr. 19, 2015 (GLOBE NEWSWIRE) -- Transposagen, a world leader in genome engineering technologies and services, announced the registration of its trademark OncoRat™ by the USPTO, for...
-
Lexington, KY, April 16, 2015 (GLOBE NEWSWIRE) -- Transposagen, a world leader in genome engineering technologies and services, announced the registration of its trademark OncoRat™ by the...
-
CAMBRIDGE, Mass. and LEXINGTON, Ky., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Stemgent, Inc., A ReproCELL Group Company (Cambridge, Massachusetts, USA) and Transposagen Biopharmaceuticals Inc. (Lexington,...
-
LEXINGTON, Ky., Nov. 24, 2014 (GLOBE NEWSWIRE) -- Transposagen Biopharmaceuticals, Inc., (Transposagen) a private biotechnology company headquartered in Lexington, KY, today announced they have...
-
LEXINGTON, Ky., Aug. 8, 2014 (GLOBE NEWSWIRE) -- In the latest demonstration of Transposagen's Footprint-Free™ Gene Editing System, published this week in Genome Research, scientists from the...